| 000 | 01189 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513050302.0 | ||
| 264 | 0 | _c19950406 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00191159 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOttervanger, J P | |
| 245 | 0 | 0 |
_aAdverse reactions attributed to sumatriptan. A postmarketing study in general practice. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1994 |
||
| 300 |
_a305-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChest Pain _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xchemically induced |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 650 | 0 | 4 |
_aSumatriptan _xadverse effects |
| 700 | 1 | _avan Witsen, T B | |
| 700 | 1 | _aValkenburg, H A | |
| 700 | 1 | _aGrobbee, D E | |
| 700 | 1 | _aStricker, B H | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 47 _gno. 4 _gp. 305-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00191159 _zAvailable from publisher's website |
| 999 |
_c7874516 _d7874516 |
||